Effect of Spironolactone in CV Mortality in Hemodialysis Patients  by Kannan, Arun et al.
J O U R N A L O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y V O L . 6 4 , N O . 5 , 2 0 1 4
ª 2 0 1 4 B Y T H E AM E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N D A T I O N I S S N 0 7 3 5 - 1 0 9 7 / $ 3 6 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C .LettersFinding ECG Readers
in Clinical Practice
Is It Time to Change the Paradigm?The standard 12-lead electrocardiogram (ECG) is the
most commonly performed cardiac diagnostic test
because it provides vital information about cardiac
rhythm, acute myocardial injury, and a host of
other abnormalities while also being simple to per-
form, risk free, and inexpensive. Historically, ECG
readers have been trained in cardiology and clinical
electrocardiography. However, mentoring of cardi-
ology trainees in clinical electrocardiography has
been superseded by a host of emerging diagnostic
and treatment modalities such as invasive pro-
cedures, imaging techniques, cardiac device thera-
pies, and cardiogenomics. As a result, there is an
ever-shrinking pool of cardiologists who have the
expertise or desire to read ECGs. In the United States,
most ECGs are read by noncardiologists (emergency,
internal-medicine, and family-practice physicians)
who have had minimal training in clinical electro-
cardiography (1). Inadequate training of ECG readers
has also led to an overreliance on computerized
measurements/interpretations that are frequently
inaccurate.
In some hospitals, there is already an inadequate
supply of ECG readers, and the problem is made worse
by minimal reimbursement from payers. The small
professional fee to a physician for reading an ECG
(about $9.00 in the San Francisco area) has forced some
hospitals to augment the professional fee at the hos-
pital’s expense in order to ﬁnd enough readers for the
large volume of ECGs generated each day.
The relevant question is whether it is time to
consider training and certifying cardiovascular nurse
practitioners to read ECGs, thereby supplementing
the shrinking pool of expert ECG readers. Cardiolo-
gists have confronted similar challenges in the past.
For example, at the initiation of coronary care units,
cardiologists delegated arrhythmia interpretation to
specially trained coronary care unit nurses (2,3). We
believe that it is time to consider training and certi-
fying nurse practitioners specializing in cardiology
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1886–93.Effect of Spironolactone
in CV Mortality
in Hemodialysis PatientsMatsumoto et al. (1) have investigated the role of
spironolactone in hemodialysis patients. The in-
vestigators have noted that spironolactone reduced
the risk of both cardiovascular morbidity and mor-
tality in hemodialysis patients. It would be inter-
esting to know the left ventricular mass index and left
ventricular ejection fraction in the study population
because these 2 parameters have been demonstrated
to be objective variables predictive of adverse car-
diovascular outcomes in patients with end-stage
renal disease (ESRD). The improved cardiovascular
outcomes could have been due to an improvement
in the aforementioned parameters (2). It would also
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529be worthwhile to know the calcium–phosphorus
product and intact parathyroid hormone level in the
study population because altered bone mineral
metabolism has been associated with increased car-
diovascular mortality in ESRD patients. Additionally,
the treatment group has a statistically signiﬁcant in-
crease in baseline serum albumin level; improved
nutritional status and decreased protein catabolic
rate may have contributed to reduced cardiovascular
morbidity and mortality in the study cohort.*Arun Kannan, MD
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Approach to Pre-Clinical
Diastolic Dysfunction?
Think About Exercise Training!In their state-of-the-art paper, Wan et al. (1) provide a
comprehensive overview of the assessment, patho-
physiology, and management of pre-clinical diastolic
dysfunction (PDD). This condition has been shown
to represent an early stage in the development of
heart failure with preserved ejection fraction
(HFpEF) and to typically be associated with cardio-
vascular risk factors such as diabetes or hyper-
tension. The authors therefore emphasize that
prevention or treatment of PDD needs to be tailored
to the underlying cardiovascular comorbidities. Very
few studies so far have directly focused on PDD, but
in a variety of recent randomized trials evaluating
different drug treatments in HFpEF, no pharmaco-
logical agent has been shown to consistently improvemarkers, symptoms, or clinical endpoints of this
condition.
Surprisingly, the authors do not report on any
nonpharmacological treatment approaches to PDD
and/or HFpEF, such as exercise training, although
reduced exercise capacity is acknowledged as a hall-
mark of HFpEF. In addition, the aforementioned un-
derlying causes and comorbidities of PDD have all
been shown to be effectively inﬂuenced by regular
exercise. Accordingly, in our multicenter, random-
ized Ex-DHF (Exercise training in Diastolic Heart
Failure) pilot trial evaluating the effects of combined
aerobic and resistance exercise in 64 patients with
HFpEF, we have recently described signiﬁcant in-
creases in exercise capacity and quality of life as
well as signiﬁcant decreases of the E/e0-ratio and
the left atrial volume index as compared with a
nonexercising control group (2). Randomized con-
trolled multicenter studies coheaded by our group are
now underway, evaluating the effects of different
exercise regimens on diastolic function and exercise
capacity in adequately powered cohorts of HFpEF
patients, including the currently highly debated
high-intensity interval training (Ex-DHF, Current
Controlled Trials number ISRCTN86879094; OptimEx
[Optimizing Exercise Training in Prevention and
Treatment of Diastolic Heart Failure], ClinicalTrials.
gov identiﬁer NCT02078947). Certainly, similar to
medical treatment approaches, exercise training will
have to prove signiﬁcant and lasting effects on
the prevention and progression of HFpEF in these
larger trials. However, the aforementioned pre-
liminary, but promising, ﬁndings suggest a clear
lifestyle association that may effectively be reversed
by interventions focusing on exercise training. This
has to be appreciated and included in treatment
recommendations.*Axel Pressler, MD
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